JP2005516994A5 - - Google Patents

Download PDF

Info

Publication number
JP2005516994A5
JP2005516994A5 JP2003565486A JP2003565486A JP2005516994A5 JP 2005516994 A5 JP2005516994 A5 JP 2005516994A5 JP 2003565486 A JP2003565486 A JP 2003565486A JP 2003565486 A JP2003565486 A JP 2003565486A JP 2005516994 A5 JP2005516994 A5 JP 2005516994A5
Authority
JP
Japan
Prior art keywords
phenyl
hydrogen
alkyl
azacycloheptan
indol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2003565486A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005516994A (ja
Filing date
Publication date
Priority claimed from GBGB0203061.7A external-priority patent/GB0203061D0/en
Application filed filed Critical
Publication of JP2005516994A publication Critical patent/JP2005516994A/ja
Publication of JP2005516994A5 publication Critical patent/JP2005516994A5/ja
Ceased legal-status Critical Current

Links

JP2003565486A 2002-02-08 2003-02-07 内臓の機能的運動障害におけるアシルアミノアルケニレン−アミド誘導体の使用 Ceased JP2005516994A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0203061.7A GB0203061D0 (en) 2002-02-08 2002-02-08 Organic compounds
PCT/EP2003/001227 WO2003066062A1 (en) 2002-02-08 2003-02-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010164587A Division JP2010241835A (ja) 2002-02-08 2010-07-22 内臓の機能的運動障害におけるアシルアミノアルケニレン−アミド誘導体の使用

Publications (2)

Publication Number Publication Date
JP2005516994A JP2005516994A (ja) 2005-06-09
JP2005516994A5 true JP2005516994A5 (cg-RX-API-DMAC10.html) 2006-03-23

Family

ID=9930743

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003565486A Ceased JP2005516994A (ja) 2002-02-08 2003-02-07 内臓の機能的運動障害におけるアシルアミノアルケニレン−アミド誘導体の使用
JP2010164587A Pending JP2010241835A (ja) 2002-02-08 2010-07-22 内臓の機能的運動障害におけるアシルアミノアルケニレン−アミド誘導体の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010164587A Pending JP2010241835A (ja) 2002-02-08 2010-07-22 内臓の機能的運動障害におけるアシルアミノアルケニレン−アミド誘導体の使用

Country Status (18)

Country Link
US (2) US20050203164A1 (cg-RX-API-DMAC10.html)
EP (2) EP1476167A1 (cg-RX-API-DMAC10.html)
JP (2) JP2005516994A (cg-RX-API-DMAC10.html)
KR (2) KR20040081492A (cg-RX-API-DMAC10.html)
CN (1) CN1301714C (cg-RX-API-DMAC10.html)
AU (1) AU2003244446B2 (cg-RX-API-DMAC10.html)
BR (1) BR0307479A (cg-RX-API-DMAC10.html)
CA (1) CA2471964A1 (cg-RX-API-DMAC10.html)
GB (1) GB0203061D0 (cg-RX-API-DMAC10.html)
IL (2) IL162816A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA04007640A (cg-RX-API-DMAC10.html)
NO (1) NO20043735L (cg-RX-API-DMAC10.html)
NZ (1) NZ534231A (cg-RX-API-DMAC10.html)
PL (1) PL370255A1 (cg-RX-API-DMAC10.html)
RU (1) RU2353356C2 (cg-RX-API-DMAC10.html)
TW (1) TWI330177B (cg-RX-API-DMAC10.html)
WO (1) WO2003066062A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200404960B (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
AU2004283038B9 (en) * 2003-10-27 2008-04-24 Novartis Ag Use of neurokinin antagonists in the treatment of urinary incontinence
JP2010502736A (ja) 2006-09-08 2010-01-28 オレ・ファーマシューティカルズ・インコーポレーテッド 消化管の炎症を低減または軽減するための方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
DE69602087T2 (de) * 1995-02-22 1999-09-09 Novartis Ag 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
PL191496B1 (pl) * 1997-07-02 2006-05-31 Merck & Co Inc Odmiana polimorficzna 2-(R)-{1-(R) -[3,5-bis(trifluorometylo)-fenylo]etoksy} -3-(S)-(4-fluoro) fenylo-4-[3-(5-okso-1H,4H-1,2,4-triazolo)metylo] morfoliny, sposób jej wytwarzania, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie
TW520370B (en) * 1998-11-20 2003-02-11 Meiji Seika Kaisha Benzooxazole derivatives and a pharmaceutical composition containing the derivatives as an active ingredient
RU2161894C1 (ru) * 1999-08-10 2001-01-20 НИФ "Ультрасан" Лечебно-профилактическая композиция
GB0010958D0 (en) 2000-05-05 2000-06-28 Novartis Ag Organic compounds
CA2432543A1 (en) * 2000-12-22 2002-07-04 Takeda Chemical Industries, Ltd. Combination drugs
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
RU2340618C2 (ru) Диазинопиримидины и фармацевтическая композиция, содержащая их
RU2471781C2 (ru) Новые двузамещенные фенилпирролидины в качестве модуляторов кортикальной катехоламинергической нейротрансмиссии
NO20051036L (no) 3,4-disubstituerte syklobuten-1,2-dioner som CXC-kjemokinreseptorligander
JP2007538024A5 (cg-RX-API-DMAC10.html)
RU2017132673A (ru) Производные собетирома
JP2007517846A5 (cg-RX-API-DMAC10.html)
CA2462453A1 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
RU2006125756A (ru) Производные 2-оксо-1-пирролидина, способ их получения и применения
JP2018511647A5 (cg-RX-API-DMAC10.html)
JP2005053931A5 (cg-RX-API-DMAC10.html)
JP2005527593A5 (cg-RX-API-DMAC10.html)
WO2004074270A3 (en) Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
RU2004126957A (ru) Пиперидиновые производные
NO20045469L (no) (S)-4-amino-5-klor-2-metoksy-N-[I-[ 1-(2-tetrahydrofurylkarbonyl)-4-piperidinylmetyl]-4-piperidinyl]benzamid, fremgangsmate for fremstilling, farmasoytiske sammensetninger inneholdende denne og intermediater derav
JP2004529145A5 (cg-RX-API-DMAC10.html)
JP2006510606A5 (cg-RX-API-DMAC10.html)
WO2024008196A8 (zh) 一类酰胺化合物及其制备方法、药物组合物和用途
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
RU2010154417A (ru) Комбинация частичного агониста никотиновых рецепторов и ингибитора ацетилхолинетеразы, содержащая ее фармацетическая композиция, и ее применение в лечении когнитивных расстройств
JP2018512406A5 (cg-RX-API-DMAC10.html)
JP2008507516A5 (cg-RX-API-DMAC10.html)
CN1100301A (zh) 用于神经保护的药物
JP2006501245A5 (cg-RX-API-DMAC10.html)
CN1130505A (zh) 5-酰基-1,4-二氢吡啶类的用途
WO2023222137A8 (zh) 新型四氢异喹啉类化合物、其制备方法、包含此类化合物的药物组合物及其用途